NOTO, Davide
 Distribuzione geografica
Continente #
NA - Nord America 16.964
EU - Europa 7.798
AS - Asia 6.985
SA - Sud America 1.183
AF - Africa 213
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 33.178
Nazione #
US - Stati Uniti d'America 16.734
SG - Singapore 2.594
RU - Federazione Russa 2.050
CN - Cina 1.814
IT - Italia 1.617
BR - Brasile 946
FI - Finlandia 888
HK - Hong Kong 699
VN - Vietnam 638
DE - Germania 630
UA - Ucraina 550
PL - Polonia 463
GB - Regno Unito 381
FR - Francia 363
IE - Irlanda 323
JP - Giappone 258
BD - Bangladesh 175
KR - Corea 147
IN - India 134
SE - Svezia 113
TR - Turchia 108
CA - Canada 107
NL - Olanda 87
AR - Argentina 81
AT - Austria 78
IQ - Iraq 72
MX - Messico 70
BE - Belgio 65
RO - Romania 52
ZA - Sudafrica 42
CI - Costa d'Avorio 39
EC - Ecuador 36
PK - Pakistan 36
ID - Indonesia 33
MA - Marocco 33
IR - Iran 31
UZ - Uzbekistan 28
CL - Cile 26
ES - Italia 26
VE - Venezuela 26
CO - Colombia 24
AZ - Azerbaigian 22
MY - Malesia 22
PH - Filippine 22
CH - Svizzera 21
AU - Australia 19
JO - Giordania 19
KE - Kenya 18
AE - Emirati Arabi Uniti 17
PY - Paraguay 17
SA - Arabia Saudita 17
DO - Repubblica Dominicana 14
DZ - Algeria 14
EG - Egitto 14
GR - Grecia 13
NP - Nepal 13
IL - Israele 12
JM - Giamaica 12
BG - Bulgaria 11
KZ - Kazakistan 11
LT - Lituania 11
PE - Perù 11
PT - Portogallo 11
TH - Thailandia 10
UY - Uruguay 10
TN - Tunisia 9
NG - Nigeria 8
PS - Palestinian Territory 8
SN - Senegal 8
BA - Bosnia-Erzegovina 7
PA - Panama 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
HN - Honduras 6
HU - Ungheria 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
BY - Bielorussia 5
GE - Georgia 5
AO - Angola 4
BH - Bahrain 4
EU - Europa 4
HR - Croazia 4
LK - Sri Lanka 4
MM - Myanmar 4
NI - Nicaragua 4
TG - Togo 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
CR - Costa Rica 3
CY - Cipro 3
ET - Etiopia 3
GT - Guatemala 3
LB - Libano 3
OM - Oman 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AL - Albania 2
CG - Congo 2
GA - Gabon 2
Totale 33.141
Città #
Fairfield 2.106
Ashburn 2.087
Singapore 1.756
Woodbridge 1.045
Chandler 998
Houston 964
Seattle 897
Wilmington 846
San Jose 767
Cambridge 676
Hong Kong 674
Ann Arbor 524
Council Bluffs 431
Zgierz 399
Moscow 345
Dublin 321
Palermo 320
Beijing 301
Medford 293
Jacksonville 284
Tokyo 240
Altamura 212
New York 210
Des Moines 208
Ho Chi Minh City 205
Dallas 204
Santa Clara 200
Princeton 183
Los Angeles 181
Lauterbourg 180
Frankfurt am Main 175
Nanjing 162
Hanoi 153
Lawrence 149
San Diego 146
Dearborn 133
Boardman 128
Helsinki 111
Tulsa 87
London 83
The Dalles 83
Shenyang 81
São Paulo 77
Hefei 76
Buffalo 72
Milan 69
Brussels 62
Nanchang 61
Changsha 59
Chicago 58
Ludwigshafen am Rhein 56
Jinan 55
Munich 53
Orem 52
Izmir 51
Hebei 50
Tianjin 47
Jiaxing 46
Nuremberg 43
Phoenix 43
Seongnam 42
Guangzhou 40
Abidjan 39
Rome 39
Shanghai 39
Amsterdam 36
Venice 36
Atlanta 34
Bremen 34
Warsaw 34
Da Nang 33
Lappeenranta 33
Rio de Janeiro 32
Chennai 30
Denver 30
Haiphong 28
Ningbo 28
Zhengzhou 28
Falls Church 27
Brooklyn 26
Hangzhou 26
Vienna 26
Washington 26
Columbus 25
Manchester 25
Norwalk 25
Paris 25
Saint Petersburg 25
Johannesburg 24
Baghdad 23
Boston 23
Dhaka 23
Montreal 23
Stockholm 23
Toronto 23
San Paolo di Civitate 22
City of London 21
Tashkent 21
Baku 20
Ottawa 20
Totale 21.715
Nome #
Multiple food hypersensitivity as a cause of refractory chronic constipation in adults 480
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 populationrepresentative studies with 141 million participants 389
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 290
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 288
TERAPIA CON STATINE IN PAZIENTI SICILIANI AFFETTI DA IPERLIPIDEMIA FAMILIARE COMBINATA 272
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 265
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 262
A NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS 259
The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation. 259
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 257
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 253
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. 253
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 251
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease 249
BETA-2-GLYCOPROTEIN I IS GROWTH REGULATED AND PLAYS A ROLE AS SURVIVAL FACTOR FOR HEPATOCYTES 248
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 248
A NOVEL APOB MUTATION IDENTIFIED BY EXOME SEQUENCING COSEGREGATES WITH STEATOSIS, LIVER CANCER AND HYPOCHOLESTEROLEMIA 247
Clinical symptoms in celiac patients on a gluten-free diet. 246
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. 245
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 245
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descent 242
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. 242
A Novel Mutation of the DHCR7 Gene in a Sicilian Compound Heterozygote with Smith-Lemli-Opitz Syndrome 240
Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study 238
Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics 238
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 236
A novel component of the metabolic syndrome : The oxidative stress 233
Chronic constipation and food intolerance: a model of proctitis causing constipation 232
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 232
Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. 231
Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. 231
A novel putative interactor for the low density lipoprotein receptor cytoplasmic domain 226
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 224
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 221
RUOLO DEL POLIMORFISMO ILE148MET DEL GENE PNPLA3 NELLA STEATOSI ASSOCIATA ALLA IPOBETALIPOPROTEINEMIA FAMILIARE 219
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS 217
Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study 216
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 215
A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia. 214
Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells 213
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. 213
The ANP Genetic Variant RS5068 is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population 208
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants 207
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 207
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins 206
Metabolomic analysis of plasma from Alzheimer disease patients 206
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 204
No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. 204
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 204
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 204
LA LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE: ANALISI DELLA CINETICA DELL’ACIDO PALMITICO MEDIANTE L’USO DI UN ISOTOPO STABILE IN UN MODELLO IN VITRO 203
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: A possible role in glucocorticoid deficiency 202
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” 202
Lipoprotein-associated phospholipase A2 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia 202
Obesity and the metabolic syndrome in a student cohort from Southern Italy 201
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 200
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 200
REPOSITIONING OF THE GLOBAL EPICENTRE OF NON-OPTIMAL CHOLESTEROL 200
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 199
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 198
A novel mutation in the Lipase Maturaction Factor 1 (LMF-1)gene responsible for severe hypertriglyceridemia 197
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 196
PREVALENCE OF ANGPTL3 AND APOB GENE MUTATIONS IN SUBJECTS WITH COMBINED HYPOLIPIDEMIA 195
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 195
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 195
Relationship of a Body Shape Index and Body Roundness Index with carotid atherosclerosis in arterial hypertension 195
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam 194
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants 193
Genetic epidemiology of ARH in Sicily 193
CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS 192
COMPOUND HETEROZYGOUS FH AND FDB: IDENTIFICATION OF A SICILIAN FAMILY HARBOURING THE FDB3531 MUTATION AND THE Y398X MUTATION OF THE LDL RECEPTOR GENE. 192
LIPASE MATURATION FACTOR 1 IS REQUIRED FOR ENDOTHELIAL LIPASE ACTIVITY 190
Role of Nutraceuticals in Hypolipidemic Therapy 190
The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction 189
Molecular diagnosis of hypobetalipoproteinemia: An ENID review 188
Prothrombotic gene variants as risk factors of acute myocardial infarction in young women. 188
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 188
Trends in Adult Body-Mass Index in 200 Countries From 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies With 19·2 Million Participants 187
Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia 186
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 186
Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. 182
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 182
NEXT GENERATION SEQUENCIN: A NEW METHODOLOGICAL APPROACH FOR THE MOLECULAR DIAGNOSIS OF GENETIC DYSLIPIDEMIAS 179
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia 178
Protein oxidation in a group of subjects with metabolic syndrome. 178
FAMILIAL HYPOBETALIPOPROTEINEMIA DUE TO APOLIPOPROTEIN B GENE MUTATIONS CAUSES INTESTINAL FAT ACCUMULATION AND LIPID MALABSORPTION. 176
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 176
ΒETA ARRESTIN-2: A NEW “ACTOR” IN THE LDL-R ENDOCYTOSIS? 175
Lipid Peroxidation, Nitric Oxide Metabolites, and Their Ratio in a Group of Subjects with Metabolic Syndrome 175
DETECTION OF NEW GENES RESPONSIBLE OF FAMILIAL RECESSIVE HYPERCHOLESTEROLEMIA: PRELIMINARY DATA FROM AN EXOME SEQUENCING APPROACH 175
Anti-PCSK9 treatment: Is ultra-low LDL always good? 175
A century of trends in adult human height 173
Clinical, molecular and functional characterization of two novel mutations associated to compound heterozygous FHBL 173
Automated untargeted stable isotope assisted lipidomics of liver cells on high glucose shows alteration of sphingolipid kinetics 172
RT-PCR and in situ hybridization analysis of apolipoprotein H expression in rat normal tissues 171
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants 171
LIPIDOMICS OF HUMAN SKIN FIBROBLASTS IN NEIMANN-PICK DISEASE TYPE C 170
HETEROGENITY OF AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN SICILY 169
A NOVEL LOSS OF FUCTION MUTATION OF PCSK9 GENE IN CAUCASIANS WITH LOW PLASMA LDL-CHOLESTEROL 169
CARDIOVASCULAR RISK FACTORS ANALYSIS OF PEDIATRIC MATABOLIC SYNDROME 168
Totale 21.452
Categoria #
all - tutte 115.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 0 0 0 0 0 202 236
2021/20222.261 92 435 104 52 60 86 95 125 364 319 123 406
2022/20232.947 316 608 60 327 339 437 172 189 308 27 110 54
2023/20241.348 63 184 98 171 87 319 115 39 22 36 39 175
2024/20253.537 72 236 236 250 131 165 279 276 296 384 498 714
2025/202611.916 795 441 691 966 1.280 1.814 1.765 1.266 934 1.538 426 0
Totale 34.307